|
Volumn 46, Issue SUPPL., 2000, Pages
|
Immune recruitment by bispecific antibodies for the treatment of Hodgkin disease
|
Author keywords
Biospecific antibodies; Hodgkin disease; Immune recruitment
|
Indexed keywords
CD16 ANTIGEN;
CD28 ANTIGEN;
CD3 ANTIGEN;
CD30 ANTIGEN;
GRANZYME A;
GRANZYME B;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY CD16;
MONOCLONAL ANTIBODY CD30;
PERFORIN;
UNCLASSIFIED DRUG;
ANIMAL MODEL;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
HODGKIN DISEASE;
HUMAN;
MOUSE;
NATURAL KILLER CELL;
NONHUMAN;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SCID MOUSE;
SIDE EFFECT;
T LYMPHOCYTE ACTIVATION;
TREATMENT OUTCOME;
TUMOR ASSOCIATED LEUKOCYTE;
|
EID: 0033759369
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/pl00014047 Document Type: Article |
Times cited : (19)
|
References (14)
|